Nanotherapeutic That Can Cross Blood-Brain Barrier, University of Delaware Study

The University of Delaware's Emily Day is a part of a team of researchers that has developed a nanotherapeutic capable of penetrating the blood-brain barrier. Previously believed impossible, the groundbreaking development could have implications in the treatment of Glioblastoma multiforme (GBM), a lethal form of malignant brain tumors that is considered one of the deadliest human cancers. It may also benefit research for neurodegenerative diseases such as Parkinson's disease, traumatic brain injury and multiple forms of cancer.

Hey, check out all the engineering jobs. Post your resume today!